Dual-signal-quenched sandwich electrochemiluminescence immunosensor via integrated nanochannel array and glucose oxidase-loaded immuno-nanogold for sensitive tumor biomarker detection
Biosensors and Bioelectronics · 2025-11 · 288 · 117828
DOI: 10.1016/j.bios.2025.117828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-11. Verfasst von Zhuxuan Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Glucose Oxidase, Biomarkers, Tumor. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Program of Zhejiang Province, Guangxi Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
A dual-signal-quenched sandwich electrochemiluminescence (ECL) immunosensor was developed for highly sensitive detection of tumor biomarkers by integrating a silica nanochannel array film (SNF) and glucose oxidase (GOD)-loaded immuno-nanogold. The SNF modified on the supporting electrode provided dual functional domains including nanochannels and the outer surface. The most commonly used ECL emitter, tris(2,2'-bipyridyl) ruthenium (Ru (bpy)32+), was enriched in the nanochannels of SNF via electrostatic interaction, significantly amplifying the original ECL signal even at low concentrations of Ru (bpy)32+. The outer surface of SNF enabled covalent immobilization of capture antibody (cAb). Gold nanoparticles co-loaded with GOD and detection antibody (dAb) formed a multienzyme-labeled nanoprobe (GOD/dAb@Au). Upon CA 199 (5 U/mL) binding, the dual-antibody sandwich immunocomplex formed on the electrode interface, decreasing the ECL signal (30.1 % reduction in the initial signal) through increased interfacial resistance and reduced Ru (bpy)32+ diffusion. Additionally, GOD catalyzed the conversion of glucose to produce H2O2, which acted as a quencher, reducing the ECL signal of Ru (bpy)32+ (16.7 % reduction in the initial signal). This dual-signal-quenching strategy enabled sensitive detection of carbohydrate antigen 19-9 (CA19-9) as a proof-of-concept demonstration with a linear range from 50 μU/mL to 50 U/mL and a low limit of detection (LOD) of 1.1 μU/mL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
- Department of Obstetrics and Gynecology, Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, China.
- General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electroni…
- School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China. Electronic address: liujy@zstu.edu.cn.
Förderung
- Science and Technology Program of Zhejiang Province
- Guangxi Key Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Shi, Z., Zhang, T., Zhao, Y., Zhou, Y., & Liu, J. (2025). Dual-signal-quenched sandwich electrochemiluminescence immunosensor via integrated nanochannel array and glucose oxidase-loaded immuno-nanogold for sensitive tumor biomarker detection. Biosensors and Bioelectronics, 288, 117828. https://doi.org/10.1016/j.bios.2025.117828
Vancouver
Shi Z, Zhang T, Zhao Y, Zhou Y, Liu J. Dual-signal-quenched sandwich electrochemiluminescence immunosensor via integrated nanochannel array and glucose oxidase-loaded immuno-nanogold for sensitive tumor biomarker detection. Biosensors and Bioelectronics. 2025;288:117828. doi:10.1016/j.bios.2025.117828
BibTeX
@article{Shi2025,
author = {Shi, Zhuxuan and Zhang, Tongtong and Zhao, Yujiao and Zhou, Yucheng and Liu, Jiyang},
title = {Dual-signal-quenched sandwich electrochemiluminescence immunosensor via integrated nanochannel array and glucose oxidase-loaded immuno-nanogold for sensitive tumor biomarker detection},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {288},
pages = {117828},
doi = {10.1016/j.bios.2025.117828}
}
EUVIMED